Estrella Biopharma Inc

XNAS: ESLA

Download real time

0.88 -0.06 (-6.38%)

72.76% Fall from 52W High

24,890 XNAS Volume

High vol. this week

XNAS 04 Apr, 2025 5:30 PM (EDT)

31.8

Market Cap

Low in industry

-0.2

Beta 1Year

Very Low volatility

Insider Trading disclosures for Estrella Biopharma Inc

The latest disclosure was made by Cheng Liu in Estrella Biopharma Inc where a trade of 490,796 Incentive Share Option done was reported to US exchanges on Oct. 30, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Cheng Liu	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Oct 2024	490,796	490,796	-		-	Incentive Share Option
Cheng Liu	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Oct 2024	509,204	509,203	-		-	Nonstatutory Share Option
Jiandong Xu	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Oct 2024	490,796	490,796	-		-	Incentive Share Option
Jiandong Xu	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Oct 2024	509,204	509,203	-		-	Nonstatutory Share Option

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Screeners based on Insider Trading and SAST parameters